CRISPR/Cas9 genome editing to treat sickle cell disease
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Autor principal: | Ullah, Mohammad |
---|---|
Otros Autores: | Islam, Farzana |
Formato: | Tesis |
Lenguaje: | English |
Publicado: |
Brac University
2023
|
Materias: | |
Acceso en línea: | http://hdl.handle.net/10361/19355 |
Ejemplares similares
-
CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
por: Maria, Amatul
Publicado: (2020) -
Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
por: Shaikat, Mahdi Mubin
Publicado: (2023) -
A review on CRISPR-Cas system based applications in Oncology
por: Sadia, Mir
Publicado: (2022) -
A review on CRISPR Technology as an Antiviral Tool
por: Srishti, Sanjida Ahmed
Publicado: (2023) -
CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy
por: Eva, Israt Ara Jannat
Publicado: (2023)